info@biomedres.us   +1 (720) 414-3554   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Mini ReviewOpen Access

Challenges in Risk Assessment and Management of Veterinary Medicines for Plants: Gaps and Reflections for an Updated Approach

Volume 5 - Issue 3

De la Torre A*2, Haro A1, Carballo M2, de la Casa I1, Rubio C1, Cortés G1 and Carapeto R1

  • Author Information Open or Close
    • 1Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Spain
    • 2INIA-CISA, Epidemiology and Environmental health, Spain

    *Corresponding author: Ana de la Torre, INIA-CISA, Epidemiology and Environmental health, 28130, Valdeolmos, Spain

Received: May 31, 2018;;;   Published: June 11, 2018

DOI: 10.26717/BJSTR.2018.05.001198

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Under the current legislation EPC [1], an Environmental Risk Assessment (ERA) is mandatory to obtain Marketing Authorization for Veterinary Medicinal Products (VMP). ERAs for VMP, plant protection products, biocides or industrial technical products, follow the General Protection Goals for ecosystems Devos

Introduction| Conclusion| Acknowledgment| References|